Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test
- PMID: 25902810
- PMCID: PMC4481014
- DOI: 10.5665/sleep.4810
Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test
Abstract
Study objectives: To validate the Sustained Attention to Response Task (SART) as a treatment effect measure in narcolepsy, and to compare the SART with the Maintenance of Wakefulness Test (MWT) and the Epworth Sleepiness Scale (ESS).
Design: Validation of treatment effect measurements within a randomized controlled trial (RCT).
Patients: Ninety-five patients with narcolepsy with or without cataplexy.
Interventions: The RCT comprised a double-blind, parallel-group, multicenter trial comparing the effects of 8-w treatments with pitolisant (BF2.649), modafinil, or placebo (NCT01067222). MWT, ESS, and SART were administered at baseline and after an 8-w treatment period. The severity of excessive daytime sleepiness and cataplexy was also assessed using the Clinical Global Impression scale (CGI-C).
Measurements and results: The SART, MWT, and ESS all had good reliability, obtained for the SART and MWT using two to three sessions in 1 day. The ability to distinguish responders from nonresponders, classified using the CGI-C score, was high for all measures, with a high performance for the SART (r = 0.61) and the ESS (r = 0.54).
Conclusions: The Sustained Attention to Response Task is a valid and easy-to-administer measure to assess treatment effects in narcolepsy, enhanced by combining it with the Epworth Sleepiness Scale.
Keywords: ESS; MWT; SART; narcolepsy; sleepiness; sustained attention; treatment effects; validation; vigilance.
© 2015 Associated Professional Sleep Societies, LLC.
Figures

Similar articles
-
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.Sleep Med. 2016 Aug;24:57-62. doi: 10.1016/j.sleep.2016.07.010. Epub 2016 Aug 22. Sleep Med. 2016. PMID: 27810187 Clinical Trial.
-
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.Lancet Neurol. 2013 Nov;12(11):1068-75. doi: 10.1016/S1474-4422(13)70225-4. Epub 2013 Oct 7. Lancet Neurol. 2013. PMID: 24107292 Clinical Trial.
-
Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.Ann Neurol. 1998 Jan;43(1):88-97. doi: 10.1002/ana.410430115. Ann Neurol. 1998. PMID: 9450772 Clinical Trial.
-
Approved and investigational uses of modafinil : an evidence-based review.Drugs. 2008;68(13):1803-39. doi: 10.2165/00003495-200868130-00003. Drugs. 2008. PMID: 18729534 Review.
-
Pharmacological management of narcolepsy with and without cataplexy.Expert Opin Pharmacother. 2017 Jun;18(8):809-817. doi: 10.1080/14656566.2017.1323877. Epub 2017 May 17. Expert Opin Pharmacother. 2017. PMID: 28443381 Review.
Cited by
-
Sleep Architecture and Daytime Sleepiness in Patients with Erectile Dysfunction.Life (Basel). 2023 Jul 11;13(7):1541. doi: 10.3390/life13071541. Life (Basel). 2023. PMID: 37511916 Free PMC article.
-
Eyelid Closure Behavior of Patients with Idiopathic and Nonorganic Hypersomnia, Narcolepsy-Cataplexy, and Healthy Controls in the Maintenance of Wakefulness Test.Nat Sci Sleep. 2023 Aug 18;15:677-690. doi: 10.2147/NSS.S408318. eCollection 2023. Nat Sci Sleep. 2023. PMID: 37621720 Free PMC article.
-
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD.Nat Sci Sleep. 2017 Aug 14;9:201-211. doi: 10.2147/NSS.S140143. eCollection 2017. Nat Sci Sleep. 2017. PMID: 28860883 Free PMC article.
-
Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review.Sleep Adv. 2024 Aug 16;5(1):zpae059. doi: 10.1093/sleepadvances/zpae059. eCollection 2024. Sleep Adv. 2024. PMID: 39211350 Free PMC article.
-
Chinese version of narcolepsy severity scale: a validation study.BMC Neurol. 2019 Dec 21;19(1):334. doi: 10.1186/s12883-019-1570-5. BMC Neurol. 2019. PMID: 31864300 Free PMC article.
References
-
- Dodel R, Peter H, Spottke A, et al. Health-related quality of life in patients with narcolepsy. Sleep Med. 2007;8:733–41. - PubMed
-
- Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5. - PubMed
-
- Fronczek R, Middelkoop HA, van Dijk JG, Lammers GJ. Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART) Sleep. 2006;29:187–91. - PubMed
-
- Van Schie MKM, Thijs RD, Fronczek R, Middelkoop HA, Lammers GJ, Van Dijk JG. Sustained attention to response task (SART) shows impaired vigilance in a spectrum of disorders of excessive daytime sleepiness. J Sleep Res. 2012;21:390–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources